The study confirmed that HSP90AA1, as a DAMP released during ICD, contributes to the activation of immune responses through interaction with pattern recognition receptors, but paradoxically, also supports tumor immune evasion in certain settings. Here, HSP90AA1 is linked to neoplasm.